TGF-beta Shield

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameTGF-beta Shield

Drug Alias NameTGF-beta antagonist (Resverlogix)

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionTransforming growth factor beta receptors antagonists

TargetsTransforming growth factor beta receptors

Therapy Area/IndicationsFibrosisGlaucomaNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesResverlogix Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesResverlogix Corp

Active IndicationsN/A

Inactive IndicationsFibrosisGlaucomaNeoplasms

ATC CodeN/A